US › Healthcare

COSCIENS Biopharma Inc. (CSCI)

US · Healthcare · Biotechnology

$7.100.00%
Last close · 2026-08-04

Latest quarter · ended 2025-06-30

Revenue
$2.7M
Revenue YoY
+17.6%
Net profit
$-2.7M
Profit YoY
-89.9%
EPS
$-0.85
Net margin
-98.3%

Key statistics

Market cap
$8.6M
Forward P/E
0.0
P/B
1.17
Book value
$2.23
EPS (TTM)
$-6.54
52-week high
$14.80
52-week low
$0.83
50-day MA
$3.33
200-day MA
$3.17
Beta
1.85

Shareholding

Insiders
1.48%
Institutions
8.93%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for COSCIENS Biopharma Inc. — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.